Related Experiment Videos
Influenza vaccination in 18 developed countries, 1980-1992
D S Fedson1, C Hannoun, J Leese
1Department of Medicine, University of Virginia School of Medicine, Charlottesville, USA.
Vaccine
|May 1, 1995
Summary
Influenza vaccine use varies significantly across 18 developed nations, with over a 10-fold difference observed. Understanding these disparities is crucial for maximizing the benefits of influenza vaccination.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Influenza remains a significant cause of preventable illness and death.
- Influenza vaccination is recommended for high-risk groups, particularly the elderly.
- International comparisons of influenza vaccine uptake are lacking.
Purpose of the Study:
- To compare influenza vaccine distribution and use across 18 developed countries.
- To identify factors associated with differences in vaccine utilization.
- To inform strategies for improving global influenza vaccine coverage.
Main Methods:
- Gathered data on influenza vaccine distribution from 18 developed countries (1980-1992).
- Analyzed per capita vaccine distribution trends over the study period.
- Examined national vaccination recommendations and reimbursement policies.
Main Results:
- Annual per capita influenza vaccine distribution varied more than 10-fold among countries in the 1980s, and over 7-fold in 1992.
- Several countries showed significant increases in vaccine use during the study period.
- Countries with universal elderly vaccination recommendations and insurance reimbursement tended to have higher vaccine use.
Conclusions:
- Substantial international variation exists in influenza vaccine distribution and uptake.
- National policies, including recommendations and reimbursement, appear to influence vaccine use.
- Further research is needed to understand historical, economic, and political factors influencing these differences to optimize influenza vaccine benefits.